Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

Cardiologists recommend complete revascularization, intravascular imaging in new ACS guidelines
The American College of Cardiology and American Heart Association published the new guidelines with assistance from other leading U.S. medical societies.
Why cardiac CT adoption remains low among primary care providers
The rapid rise of CCTA represents one of cardiology’s biggest ongoing trends, but most primary care providers are still not embracing a CT-first strategy.
Medtronic enrolls first patient in new coronary DCB trial—data could lead to FDA approval
The paclitaxel-coated device, already approved in Europe and other parts of the world, will be tested on more than 1,200 patients for a new international trial. If the study is a success, Medtronic hopes to gain regulatory approval in the United States and Japan.
AI leader Heartflow enters new era focused on delivering personalized care for CAD patients
The company's AI-powered CCTA assessments have already been used to help manage more than 400,000 heart patients around the world.
Aspartame linked to surging insulin levels, fatty plaques and inflammation
Aspartame, the artificial sweetener commonly found in diet sodas and sugar-free snacks, may do significant harm to a person’s cardiovascular system.

Adults with acute coronary syndrome in registry differ from those in clinical trial

A registry analysis found that approximately one-third of patients who currently have acute coronary syndrome would have qualified for the IMPROVE-IT trial, which enrolled patients between 2005 and 2010.

Cardiovascular societies release AUC for revascularization in patients with ACS

Several medical societies recently released updated appropriate use criteria (AUC) for coronary revascularization in patients with acute coronary syndromes (ACS).

Around the web

Radiology Business

The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Radiology Business

Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Acute Coronary Syndromes

Cardiologists recommend complete revascularization, intravascular imaging in new ACS guidelines

Why cardiac CT adoption remains low among primary care providers

Medtronic enrolls first patient in new coronary DCB trial—data could lead to FDA approval

AI leader Heartflow enters new era focused on delivering personalized care for CAD patients

Aspartame linked to surging insulin levels, fatty plaques and inflammation

Around the web